Company Encyclopedia
View More
name
YHLO
688575.SH
Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers chemiluminescence immunoassay analyzer, diabetes solution, automated biochemical analyzer, laboratory automation, tenfly phoenix blot analyzer, VISION Pro ESR analyzer, and VISION ESR analyzer. The company was founded in 2008 and is headquartered in Shenzhen, China.
866.20 B
688575.SHMarket value -Rank by Market Cap -/-

Financial Score

16/12/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking38/63
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE5.35%C
    • Profit Margin7.53%B
    • Gross Margin60.98%A
  • Growth ScoreC
    • Revenue YoY0.13%C
    • Net Profit YoY-50.35%D
    • Total Assets YoY3.68%C
    • Net Assets YoY1.63%C
  • Cash ScoreC
    • Cash Flow Margin1328.85%B
    • OCF YoY0.13%C
  • Operating ScoreC
    • Turnover0.46C
  • Debt ScoreB
    • Gearing Ratio37.65%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    YHLO Biotech Gets Dutch Certification for HIV Kit

    YHLO Biotech Gets Dutch Certification for HIV Kit

    marketscreener·
    SH
    688575
    -0.64%
    marketscreener·
    SH
    688575
    -0.64%

    YHLO Biotech Gets Guangdong Registrations for sST2 Test Kit, Microfluidic Analyzer

    YHLO Biotech Gets Guangdong Registrations for sST2 Test Kit, Microfluidic Analyzer

    marketscreener·
    SH
    688575
    -0.64%
    marketscreener·
    SH
    688575
    -0.64%

    Shenzhen YHLO Biotech Gets Guangdong, China Regulatory Approval for Detection Kit

    Shenzhen YHLO Biotech Gets Guangdong, China Regulatory Approval for Detection Kit

    marketscreener·
    SH
    688575
    -0.64%
    marketscreener·
    SH
    688575
    -0.64%

    YHLO Biotech Gets Registration Certificate for Human Chorionic Gonadotropin Kit

    YHLO Biotech Gets Registration Certificate for Human Chorionic Gonadotropin Kit

    marketscreener·
    SH
    688575
    -0.64%
    marketscreener·
    SH
    688575
    -0.64%

    Ningbo Donly Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025

    Ningbo Donly Co.,Ltd reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 1,115.1 million compared to CNY 1,083.7 million a year ago. Net income was CNY 58.46 million compared to CNY 42.72 million a year ago.Basic earnings per share from continuing operations was CNY 0.11 compared to CNY 0.08 a year ago. Diluted earnings per share from continuing operations was CNY 0.11 compared to CNY 0.08 a year ago.

    marketscreener·
    SZ
    002164
    +0.90%
    marketscreener·
    SZ
    002164
    +0.90%
    © 2025 Longbridge｜Disclaimer